Canada’s Parvus Therapeutics has signed a deal with Roche’s Genentech unit to develop, manufacture and market drugs for inflammatory bowel disease, autoimmune liver diseases, and coeliac disease.

Distal iliac arteries were perfused by lumbar and abdominal wall collateral circulation (figure 1). A complementary arterial doppler was performed, depicting ‘tardus parvus’ waveforms in distal iliac ...